$ERNA +43% 🚀 🔹 Massive move as Ernexa gains attention after new ERNA-101 ovarian cancer data 📈 🔹 Preclinical results showed 100% survival and complete tumor

$ERNA +43% 🚀 🔹 Massive move as Ernexa gains attention after new ERNA-101 ovarian cancer data 📈 🔹 Preclinical results showed 100% survival and complete tumor elimination when combined with anti-PD-1 therapy 🔬 🔹 Company is developing engineered iMSC-based cell therapies targeting cancer and auto…